Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
10/04/2023 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 372.7k | $0.24 | $89.4k | | 10/04/2023 |
03/29/2023 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 41.1k | $1.05 | $43.1k | | 03/29/2023 |
10/07/2022 | Outlook Therapeutics, Inc. | ONS | Purchase | Common Stock | 30k | $1.29 | $38.7k | | 10/07/2022 |
10/05/2022 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 74.9k | $1.25 | $93.6k | | 10/05/2022 |
04/21/2022 | Outlook Therapeutics, Inc. | ONS | Other (acquisition) | Common Stock | 28M | $0.00 | $0 | See Footnotes | 04/21/2022 |
03/23/2022 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 21.9k | $1.92 | $42k | | 03/23/2022 |
12/02/2021 | Outlook Therapeutics, Inc. | ONS | Purchase | Common Stock | 18k | $1.40 | $25.2k | | 12/02/2021 |
10/05/2021 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 44.8k | $2.12 | $94.9k | | 10/05/2021 |
04/19/2021 | Outlook Therapeutics, Inc. | ONS | Purchase | Common Stock | 10k | $1.82 | $18.2k | | 04/19/2021 |
03/24/2021 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 20.9k | $2.27 | $47.4k | | 03/24/2021 |
10/05/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 151.7k | $0.71 | $107k | | 10/01/2020 |
10/01/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 296.4k | $0.71 | $210.4k | | 10/01/2020 |
09/17/2020 | Outlook Therapeutics, Inc. | ONS | Purchase | Common Stock | 10k | $0.67 | $6.7k | | 09/17/2020 |
07/17/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 135k | $1.58 | $213.3k | | 07/17/2020 |
03/19/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 15k | $0.54 | $8.1k | | 03/19/2020 |
10/03/2019 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 15k | $1.40 | $21k | | 10/03/2019 |
10/03/2019 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 86.8k | $1.40 | $121.5k | | 10/03/2019 |
10/31/2017 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 25k | $1.26 | $31.5k | | 10/31/2017 |